Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Darbepoetin Alfa (Aranesp) Market for the Period 2024 to 2033?

The market for darbepoetin alfa (aranesp) has seen robust growth in recent times, expanding from $5.56 billion in 2023 to an expected $5.88 billion in 2024, illustrating a compound annual growth rate (CAGR) of 5.7%. The considerable growth experienced in the past is a result of several factors, including advancements in treatments for anemia, higher demand for erythropoiesis-stimulating agents (esa), innovative developments in biopharmaceuticals, increased clinical acceptance, and improved patient outcomes.

The market for darbepoetin alfa (aranesp) is projected to experience consistent expansion in the coming years, reaching a valuation of $7.11 billion by 2028, with a compound annual growth rate (CAGR) of 4.8%. The projected development during the forecast duration can be credited to factors such as healthcare reimbursement policies, an upswing in awareness and education, development of healthcare infrastructure, the rising demand for renal care, and an increasingly elderly population. Key trends anticipated during the forecast period encompass global market penetration, the integration of digital health, personalised treatment methodologies, the embracement of biosimilars, and long-acting formulations.

Claim Your Free Sample of the Global Darbepoetin Alfa (Aranesp) Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12171&type=smp

What Factors Are Responsible for the Growth of the darbepoetin alfa (aranesp) Market?

The escalation in chronic disease cases is likely to fuel the expansion of the darbepoetin alfa market in the future. Chronic diseases are illnesses that last at least three months and may worsen over time. Darbepoetin alfa has been employed in treating various chronic ailments and counteracting anemia resulting from chemotherapy in cancer. For example, the National Library of Medicine, an agency based in the US, predicted in January 2023 that the number of individuals in the US aged 50 and older with at least one chronic illness would surge by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Hence, the rise in chronic disease prevalence is propelling the darbepoetin alfa market’s growth.

Which Segments Are Important for Insight into the Darbepoetin Alfa (Aranesp) Market?

1) By Type: Epogen, Procrit, Aranesp, Other Types

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Application: Patients with Chronic Kidney Disease, Patients with Cancer, Other Applications

What Are the Significant Trends Reshaping the Darbepoetin Alfa (Aranesp) Sector?

Major players in the darbepoetin alfa market are relying on product innovations as a key strategy to solidify their market position. An example of this trend is how GlaxoSmithKline. Ltd, a pharmaceutical and biotechnology company based in the UK, adopted new technologies and launched Jesduvroq (daprodustat) in February 2023 with the approval of the US Food and Drug Administration (FDA). Daprodustat, also known as recombinant human erythropoietin (rhEPO, darbepoetin alfa or epoetin alfa) is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. It’s used as a once-daily treatment for anemia resulting from chronic kidney disease (CKD) in individuals who have been undergoing dialysis for no less than four months.

Order Now for Fast Delivery of Your Darbepoetin Alfa (Aranesp) Market Report!

https://www.thebusinessresearchcompany.com/report/darbepoetin-alfa-aranesp-global-market-report

Which Regions Are Essential for the Growth of the Darbepoetin Alfa (Aranesp) Market?

North America was the largest region in the darbepoetin alfa market in 2023. The regions covered in the darbepoetin alfa (aranesp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Darbepoetin Alfa (Aranesp) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the darbepoetin alfa (aranesp) market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Darbepoetin Alfa (Aranesp) Market Include

1. Darbepoetin Alfa (Aranesp) Market Executive Summary

2. Darbepoetin Alfa (Aranesp) Market Segments

3. Darbepoetin Alfa (Aranesp) Market Size And Template Market Growth Rate

4. Key Darbepoetin Alfa (Aranesp) Market Trends

5. Major Darbepoetin Alfa (Aranesp) Market Drivers

……

25. Key Mergers And Acquisitions In The Darbepoetin Alfa (Aranesp) Market

26. Top Darbepoetin Alfa (Aranesp) Companies

27. Darbepoetin Alfa (Aranesp) Market Opportunities And Strategies

28. Darbepoetin Alfa (Aranesp) Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: